Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non small-cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Quinoxalines
  • Sulfanilamides

abstract

  • When given on this schedule CQS is inactive in NSCLC despite the fact that the target concentration was achieved in 90% of patients. The ability of the HTCFA to identify active agents remains unproved.

publication date

  • August 29, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s002800050679

PubMed ID

  • 9272118

Additional Document Info

start page

  • 415

end page

  • 8

volume

  • 40

number

  • 5